Market Place
Sourcing Support
Notice Of Annual General Meeting In Alligator Bioscience AB
30 Mar 2026 //
PHARMIWEB
Alligator Bioscience Board Proposals For AGM Announced
27 Mar 2026 //
PHARMIWEB
Alligator Bioscience Publishes Annual Report For 2025
26 Mar 2026 //
PHARMIWEB
Alligator Bioscience AB: Change in Shares and Votes
30 Jan 2026 //
PHARMIWEB
Alligator Bio Announces Preliminary Outcome in Rights Issue
19 Dec 2025 //
PHARMIWEB
Alligator Publishes Supplement Prospectus
03 Dec 2025 //
PHARMIWEB
Alligator Bioscience Publishes Financial Calendar For 2026
03 Dec 2025 //
PHARMIWEB
Alligator Bioscience Adds New Rights Commitments
01 Dec 2025 //
PHARMIWEB
Alligator Bioscience AB Holds Extraordinary General Meeting
25 Nov 2025 //
PHARMIWEB
Alligator Bio Calls Extraordinary General Meeting
22 Oct 2025 //
ACCESSWIRE
Alligator Bio Raises SEK120M via Rights Issue and Bridge Loans
22 Oct 2025 //
ACCESSWIRE
Alligator Bioscience AB Discloses Results of Warrants Series
17 Sep 2025 //
ACCESSWIRE
Alligator Bioscience Announces Outcome of Warrants Series TO 13
16 Sep 2025 //
ACCESSWIRE
Alligator Bioscience Warrants Series TO 13 Trading Ends Sept 11
11 Sep 2025 //
PHARMAWEB
Alligator Bio Renegotiates Loan, Receives Subscription Intentions
08 Sep 2025 //
ACCESSWIRE
Alligator Bioscience Shares R&D Event 2025 Highlights
20 Aug 2025 //
ACCESSWIRE
Alligator Bioscience Reports Q2 2025 Financial Results
10 Jul 2025 //
ACCESSWIRE
Alligator Issues Shares Linked to TO 12 Warrants
26 May 2025 //
ACCESSWIRE
Alligator Bioscience to Attend ASCO 2025 Annual Meeting
12 May 2025 //
ACCESSWIRE
Alligator Secures TO 12 Program, Renegotiates Outstanding Loan
09 May 2025 //
ACCESSWIRE
Change in Number of Shares and Votes in Alligator Bioscience AB
30 Apr 2025 //
ACCESSWIRE
Exercise Price Set for Warrant Series TO 12 in Alligator Bioscience
28 Apr 2025 //
ACCESSWIRE
Notice of Annual General Meeting in Alligator Bioscience AB
02 Apr 2025 //
ACCESSWIRE
Alligator Bioscience Sets Record Date for Reverse Share Split
01 Apr 2025 //
ACCESSWIRE
Change in Number of Shares and Votes in Alligator Bioscience AB
31 Mar 2025 //
#N/A
Bulletin from Extraordinary Alligator Bioscience AB Meeting
27 Mar 2025 //
ACCESSWIRE
Alligator Bioscience Publishes Annual Report for 2024
27 Mar 2025 //
ACCESSWIRE
Exercise Price Set for Alligator Bioscience Warrants Series TO 9
02 Dec 2024 //
ACCESSWIRE
Aptevo And Alligator Announce ALG.APV-527 Trial Data
16 Sep 2024 //
ACCESSWIRE
Aptevo And Alligator Present ALG.APV-527 Data For Solid Tumors At ESMO
13 Sep 2024 //
ACCESSWIRE
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
04 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Orion & Alligator reveal second stage of immuno-oncology research collaboration
03 Jan 2023 //
PHARMA TIMES
Alligator Announces +ve Interim Results from Mitazalimab OPTIMIZE-1 Ph 2 Trial
02 Jan 2023 //
PIPELINEREVIEW
Alligator Bioscience & Aptevo Announce Publication Highlighting ALG.APV-527 s
09 Nov 2022 //
ACCESSWIRE
Alligator Announces IND Approval for Second Phase 2 Clinical Trial of AC101
08 Nov 2022 //
PRESS RELEASE
Alligator Bioscience announces positive safety data from ATOR-1017 study
30 Sep 2022 //
PHARMATIMES
Alligator Bioscience and Aptevo Therapeutics Announce that FDA has Issued
19 Sep 2022 //
ACCESSWIRE
Alligator Bioscience Presents Additional Data from mitazalimab OPTIMIZE-1
14 Sep 2022 //
MFN
Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update
23 Mar 2022 //
PRNEWSWIRE
Alligator Bio initiates sponsored research agreement with UPENN
20 Jan 2022 //
PHARMABIZ
Alligator reports update on-going OPTIMIZE-1 phase Ib/II trial with mitazalimab
19 Jan 2022 //
PHARMABIZ
Alligator Announces Trial Update and Early Readout for ATOR-1017
15 Dec 2021 //
PRNEWSWIRE
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
08 Nov 2021 //
PRNEWSWIRE
Alligator is exploring financing alternatives to support phase II studies
02 Sep 2021 //
PRNEWSWIRE
Alligator announces Collaboration and License Agreement with Orion Corporation
18 Aug 2021 //
PRNEWSWIRE
Article on CD40 agonistic antibodies published in Expert Opinion
07 Jun 2021 //
BIOSPACE
Alligator`s mitazalimab shown to enhance cancer vaccine
06 May 2021 //
PRNEWSWIRE
Alligator & MacroGenics Enter into a Research Collaboration to Develop
16 Apr 2021 //
PRNEWSWIRE
Alligator and MacroGenics Enter into a Research Collaboration
15 Apr 2021 //
BIOSPACE
Alligator Bioscience appoints Søren Bregenholt as new CEO
18 Mar 2021 //
PRNEWSWIRE
Alligator Bioscience appoints Søren Bregenholt as new CEO
18 Mar 2021 //
PRNEWSWIRE
Alligator Bioscience publishes Annual Report for 2020
18 Mar 2021 //
PRNEWSWIRE
Alligator Bioscience AB: Year-end Report January-December 2020
26 Feb 2021 //
PRNEWSWIRE
Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1
28 Dec 2020 //
PRNEWSWIRE
Alligator Bioscience recruits new Chief Medical Officer
28 Dec 2020 //
PRNEWSWIRE
Alligator seeks regulatory approval to begin ph II OPTIMIZE-1 of mitazalimab
28 Dec 2020 //
PHARMABIZ
Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1
28 Dec 2020 //
PRNEWSWIRE
Alligator Bioscience recruits new Chief Medical Officer
28 Dec 2020 //
PRNEWSWIRE
Alligator seeks regulatory approval to begin ph II OPTIMIZE-1 of mitazalimab
28 Dec 2020 //
PHARMABIZ
Alligator Bioscience`s IND for CD40 antibody mitazalimab gets US FDA approval
06 Dec 2020 //
PHARMABIZ
